Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1318/week)
    • Manufacturing(660/week)
    • Energy(518/week)
    • Technology(1271/week)
    • Other Manufacturing(448/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

RTT

Aug 14, 2020
Phase 2/3 trial suggests that AMZELL's new topical treatment (AMZ001) for the treatment of knee osteoarthritis symptoms is effective
Aug 14, 2020
Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Aug 14, 2020
Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results
Aug 14, 2020
Alzheimer's Foundation of America Announces Virtual Professional Training Programs
Aug 14, 2020
Combating Skin Cancer on the Front Lines: DermaSensor Inc. Unveils Its Decade Of Clinical Research on Elastic Scattering Spectroscopy and Skin Cancer
Aug 14, 2020
Izabela Podgorski, Ph.D., researcher at Karmanos Cancer Institute receives RO1 grant to continue research on metastatic prostate cancer
Aug 13, 2020
Seoul Viosys to Develop a Cancer Diagnosis Technology for Companion Animals with Violeds Technology
Aug 13, 2020
Novartis announces FDA filing acceptance of Xolair® (omalizumab) prefilled syringe for self-administration across all indications
Aug 13, 2020
PIQRAY® is approved and now available in Canada as the first and only treatment specifically for patients with a PIK3CA mutation in HR-positive, HER2-negative advanced breast cancer
Aug 13, 2020
Three Lakes Foundation and MATTER to hold an Innovation Challenge for Pulmonary Fibrosis
Aug 13, 2020
ViaCyte Appoints Dr. Manasi Sinha Jaiman as Vice President, Clinical Development
Aug 13, 2020
Hoth Therapeutic Announces That It Has Submitted its Request to Australia Ethics Board to Begin Clinical Trial of BioLexa for Atopic Dermatitis
Aug 13, 2020
The New England Center for Children Celebrates 45th Anniversary
Aug 13, 2020
Tissue Diagnostics Market To Reach USD 5.02 Billion By 2027 | Reports And Data
Aug 13, 2020
Real-World Study Shows OneTouch Reveal® Plus Digital Coach Drives Positive Health Outcomes
Aug 13, 2020
Global Hepatitis B Tests Industry 2015-2030: COVID-19 Impact, Revenues by Segment, Total Procedures, Units, ASPs, and Market Values by Segment
Aug 13, 2020
Study: Medical Marijuana Associated with Fewer Hospitalizations for Individuals Living with Sickle Cell Disease
Aug 13, 2020
Tick Population Rising in Many Areas, Resulting in Surge of Lyme Disease Cases in Dogs
Aug 13, 2020
Global Market and Forecast Model for Hepatitis C Tests Market 2020 with Coverage of 39 Countries
Aug 13, 2020
UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc.
  •  
  • Page 1
  • ››

Latest News

May 21, 2025

Cool Company Ltd. Q1 2025 Business Update

May 21, 2025

Centuri Announces Pricing of Secondary Public Offering of Common Stock

May 21, 2025

Leonardo and Weststar launch major government rotorcraft expansion and modernization programme in Malaysia...

May 21, 2025

United Alloy Expands New Manufacturing Facility in Dayton Region

May 21, 2025

Centuri Announces Launch of Secondary Public Offering of Common Stock

May 21, 2025

Sinch Recognized as a Leading RCS Vendor in ROCCO's 2024 Market Impact Report

May 21, 2025

Triskell Software named a Representative Vendor for 2025 Gartner® Market Guide for Enterprise Agile Planning...

May 21, 2025

Aquaporin Q1 2025 Trading Statement - maintains full-year financial guidance for 2025

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia